Research / ASAN / Fundamental state Inspectable configuration
State dimensions Filing 0001477720-22-000012 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
10.99% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-22.14% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
66.71% · CORE · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
89.72% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-70.07% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
53.67% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
27.62% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 24 states Self-history eligible
Oct 31, 2021 0/7 normalized Level 3 Jan 31, 2022 0/7 normalized Level 3 Apr 30, 2022 0/7 normalized Level 3 Jul 31, 2022 0/7 normalized Level 3 Oct 31, 2022 4/7 normalized Level 3 Jan 31, 2023 6/7 normalized Level 3 Apr 30, 2023 6/7 normalized Level 3 Jul 31, 2023 6/7 normalized Level 3 Oct 31, 2023 7/7 normalized Level 3 Jan 31, 2024 7/7 normalized Level 3 Apr 30, 2024 7/7 normalized Level 3 Jul 31, 2024 7/7 normalized Level 3 Oct 31, 2024 7/7 normalized Level 3 Jan 31, 2025 7/7 normalized Level 3 Apr 30, 2025 7/7 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 10.71%
Current 10.99%
Delta 0.28% Cash Generation Increased
Previous -28.40%
Current -22.14%
Delta 6.26% Growth Decreased
Previous 70.34%
Current 66.71%
Delta -3.63% Margin Decreased
Previous 90.45%
Current 89.72%
Delta -0.73% Profitability Decreased
Previous -67.86%
Current -70.07%
Delta -2.21% R And D Intensity Increased
Previous 53.61%
Current 53.67%
Delta 0.07% Sbc Intensity Increased
Previous 25.77%
Current 27.62%
Delta 1.85% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.